文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

语言障碍与使用口译员对中枢神经系统恶性肿瘤及骨转移患者希望水平的影响

Effect of Language Barriers and Use of Interpreters on Hope Among Patients With Central Nervous System Malignancies and Bone Metastases.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2023-12-05

本研究前瞻性收集2022年10月至2023年4月在本机构两个放射肿瘤科就诊患者的成人气质性希望量表(AHS)评分,共197例应答。需要口译员的患者总体AHS评分(均值45.4 vs 51.2,P=0.0493)和路径思维评分(均值21.5 vs 25.7,P=0.0085)显著低于不需要口译员的患者;体能状态较差者总体AHS评分显著更差(Pearson相关系数=-0.2703,P=0.0003)。

要点

  • 需要口译员的患者总体AHS评分均值45.4,低于不需要口译员者的51.2(P=0.0493)。
  • 需要口译员的患者路径思维评分均值21.5,低于不需要口译员者的25.7(P=0.0085)。
  • 体能状态较差与总体AHS评分更差相关(Pearson相关系数=-0.2703,P=0.0003)。

核心结论

  • 需要口译员的中枢神经系统疾病或骨转移患者AHS评分较低,提示语言障碍可能与希望水平相关。
  • 作者认为,解决患者语言障碍并进一步研究语言障碍与希望的可能关联,或可改善这些患者的希望、生活质量与结局。

研究设计与样本

  • 前瞻性收集2022年10月至2023年4月在本机构两个放射肿瘤科就诊患者的AHS评分。
  • 共197例患者应答,中位年龄60.5岁(范围16.9-92.5岁),男性占60.9%,白人占59.4%,恶性疾病占59.4%。
  • 采用最小二乘法拟合一般线性模型及Pearson相关系数分析AHS评分与社会经济及疾病因素的关系。

主要发现

  • 总体AHS评分中位数54(范围8-64),路径思维与能动思维评分中位数均为27(范围4-32)。
  • 需要口译员者 vs 不需要口译员者总体AHS评分均值45.4 vs 51.2(P=0.0493)。
  • 需要口译员者 vs 不需要口译员者路径思维评分均值21.5 vs 25.7(P=0.0085)。
  • 体能状态较差者总体AHS评分显著更差(Pearson相关系数=-0.2703,P=0.0003)。

关键数值与推荐

  • AHS为12条目问卷,通过能动(目标导向能量)和路径(达成目标的计划)两个特质测量希望。
  • AHS总分范围8-64,分数越高反映能动与路径思维越高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Hope is important in serious illnesses, as it has been linked to patient quality of life. We aimed to determine factors associated with lower hope scores among patients with central nervous system disease or bone metastases. METHODS AND MATERIALS: The Adult Dispositional Hope Scale (AHS) is a 12-item questionnaire that measures hope through 2 qualities: agency (goal-directed energy) and pathways (plan to meet goals). Total scores range from 8 to 64, with higher scores reflecting higher agency and pathways thinking. We prospectively collected scores from patients seen in 2 radiation oncology clinics at our institution from October 2022 to April 2023. The method of least squares to fit general linear models and Pearson's correlation coefficients was used to determine relationships between AHS score and socioeconomic and disease factors. RESULTS: Of the 197 patients who responded, the median age was 60.5 years (range, 16.9-92.5 years) and most patients were male (60.9%), were White (59.4%), and had malignant disease (59.4%). The median overall AHS score was 54 (range, 8-64), and median pathway and agency thinking scores were 27 (range, 4-32) and 27 (range, 4-32), respectively. Patients who needed an interpreter compared with those who did not had significantly lower overall AHS scores (mean score, 45.4 vs 51.2, respectively; P = .0493) and pathway thinking scores (mean score, 21.5 vs 25.7, respectively; P = .0085), and patients with poorer performance status had significantly worse overall AHS scores (Pearson's correlation coefficient = -0.2703, P = .0003). CONCLUSIONS: Patients with central nervous system disease or bone metastases requiring the use of an interpreter had lower AHS scores, highlighting the possible association of language barriers to hope. Addressing patient language barriers and further studies on the possible association of language barriers to hope may improve hope, quality of life, and outcomes among these patients.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Hui C, Hall J, Fang Z, et al. Effect of Language Barriers and Use of Interpreters on Hope Among Patients With Central Nervous System Malignancies and Bone Metastases. Int J Radiat Oncol Biol Phys. 2023. PMID: 38056777. doi:10.1016/j.ijrobp.2023.11.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。